First Heartland Consultants Inc. Acquires 34 Shares of Chemed Co. (NYSE:CHE)

First Heartland Consultants Inc. boosted its holdings in shares of Chemed Co. (NYSE:CHE) by 7.2% in the third quarter, Holdings Channel reports. The firm owned 508 shares of the company’s stock after purchasing an additional 34 shares during the quarter. First Heartland Consultants Inc.’s holdings in Chemed were worth $305,000 at the end of the most recent reporting period.

A number of other hedge funds and other institutional investors have also recently added to or reduced their stakes in CHE. GAMMA Investing LLC lifted its stake in Chemed by 34.4% during the second quarter. GAMMA Investing LLC now owns 86 shares of the company’s stock worth $47,000 after purchasing an additional 22 shares during the period. American National Bank & Trust bought a new position in shares of Chemed in the third quarter valued at approximately $61,000. EntryPoint Capital LLC raised its stake in shares of Chemed by 14.0% in the first quarter. EntryPoint Capital LLC now owns 147 shares of the company’s stock valued at $94,000 after acquiring an additional 18 shares during the last quarter. Mather Group LLC. raised its stake in shares of Chemed by 60.5% in the second quarter. Mather Group LLC. now owns 183 shares of the company’s stock valued at $99,000 after acquiring an additional 69 shares during the last quarter. Finally, Quarry LP raised its stake in shares of Chemed by 721.7% in the second quarter. Quarry LP now owns 189 shares of the company’s stock valued at $103,000 after acquiring an additional 166 shares during the last quarter. Institutional investors own 95.85% of the company’s stock.

Chemed Trading Down 0.0 %

NYSE:CHE opened at $565.37 on Thursday. Chemed Co. has a 1 year low of $523.33 and a 1 year high of $654.62. The firm has a 50 day moving average of $580.85 and a 200-day moving average of $565.47. The stock has a market capitalization of $8.51 billion, a P/E ratio of 28.57, a price-to-earnings-growth ratio of 2.40 and a beta of 0.46.

Chemed (NYSE:CHE) last issued its quarterly earnings results on Tuesday, October 29th. The company reported $5.64 earnings per share for the quarter, missing analysts’ consensus estimates of $5.76 by ($0.12). The company had revenue of $606.18 million during the quarter, compared to analyst estimates of $612.22 million. Chemed had a net margin of 12.69% and a return on equity of 27.86%. The business’s revenue for the quarter was up 7.4% on a year-over-year basis. During the same period in the prior year, the business earned $5.32 EPS. As a group, analysts forecast that Chemed Co. will post 21.43 EPS for the current fiscal year.

Chemed Dividend Announcement

The business also recently declared a quarterly dividend, which will be paid on Friday, December 6th. Investors of record on Monday, November 18th will be issued a $0.50 dividend. This represents a $2.00 dividend on an annualized basis and a dividend yield of 0.35%. The ex-dividend date is Monday, November 18th. Chemed’s dividend payout ratio is currently 10.11%.

Insider Activity at Chemed

In related news, Director Andrea R. Lindell sold 831 shares of the firm’s stock in a transaction that occurred on Friday, August 16th. The shares were sold at an average price of $571.51, for a total value of $474,924.81. Following the completion of the sale, the director now owns 5,725 shares of the company’s stock, valued at $3,271,894.75. This trade represents a 0.00 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is available at the SEC website. In other Chemed news, CEO Kevin J. Mcnamara sold 2,000 shares of Chemed stock in a transaction on Thursday, September 26th. The shares were sold at an average price of $598.81, for a total transaction of $1,197,620.00. Following the completion of the sale, the chief executive officer now owns 103,735 shares of the company’s stock, valued at approximately $62,117,555.35. The trade was a 0.00 % decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, Director Andrea R. Lindell sold 831 shares of Chemed stock in a transaction on Friday, August 16th. The stock was sold at an average price of $571.51, for a total transaction of $474,924.81. Following the sale, the director now directly owns 5,725 shares of the company’s stock, valued at $3,271,894.75. This represents a 0.00 % decrease in their position. The disclosure for this sale can be found here. Insiders sold a total of 5,144 shares of company stock valued at $3,002,419 over the last quarter. Corporate insiders own 3.32% of the company’s stock.

Analyst Ratings Changes

Separately, Royal Bank of Canada cut their target price on shares of Chemed from $697.00 to $633.00 and set an “outperform” rating for the company in a research note on Tuesday, November 5th.

Chemed Company Profile

Chemed Corporation provides hospice and palliative care services to patients through a network of physicians, registered nurses, home health aides, social workers, clergy, and volunteers primarily in the United States. The company operates in VITAS and Roto-Rooter segments. It offers plumbing, drain cleaning, excavation, water restoration, and other related services to residential and commercial customers through company-owned branches, independent contractors, and franchisees.